These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 14036638)

  • 21. Synthesis and antibacterial activity of 4-benzoyl-1-methyl-5-phenyl-1H-pyrazole-3-carboxylic acid and derivatives.
    Akbas E; Berber I; Sener A; Hasanov B
    Farmaco; 2005 Jan; 60(1):23-6. PubMed ID: 15652364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial activity screening of some sulfonamide derivatives on some Nocardia species and isolates.
    Isik K; Ozdemir-Kocak F
    Microbiol Res; 2009; 164(1):49-58. PubMed ID: 17329088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of new 5-amino-1,3,4-thiadiazole-2-sulfonamide derivatives on human carbonic anhydrase isozymes.
    Kasimoğullari R; Bülbül M; Günhan H; Güleryüz H
    Bioorg Med Chem; 2009 May; 17(9):3295-301. PubMed ID: 19362844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carbonic anhydrase inhibitors: synthesis and inhibition studies against mammalian isoforms I-XV with a series of 2-(hydrazinocarbonyl)-3-substituted-phenyl-1H-indole-5-sulfonamides.
    Güzel O; Innocenti A; Scozzafava A; Salman A; Parkkila S; Hilvo M; Supuran CT
    Bioorg Med Chem; 2008 Oct; 16(20):9113-20. PubMed ID: 18819811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel pyrazole derivatives as potential promising anti-inflammatory antimicrobial agents.
    Bekhit AA; Ashour HM; Guemei AA
    Arch Pharm (Weinheim); 2005 Apr; 338(4):167-74. PubMed ID: 15864786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Contribution to the pharmacology of 3-sulfanilamido-2-phenyl-pyrazole].
    CUGURRA F; BRAMBILLA G
    Boll Soc Ital Biol Sper; 1959 Jun; 35(11):605-7. PubMed ID: 13671152
    [No Abstract]   [Full Text] [Related]  

  • 27. [Absorption, urinary elimination & clinical toxicity of 3-(p-aminobenzenesulfonamido)-2-phenyl-pyrazole].
    ZANGAGLIA O; FERRATA A; CAMBIERI F
    Minerva Med; 1958 Dec; 49(100):4713-24. PubMed ID: 13622385
    [No Abstract]   [Full Text] [Related]  

  • 28. Synthesis and leishmanicidal activities of 1-(4-X-phenyl)-N'-[(4-Y-phenyl)methylene]-1H-pyrazole-4-carbohydrazides.
    Bernardino AM; Gomes AO; Charret KS; Freitas AC; Machado GM; Canto-Cavalheiro MM; Leon LL; Amaral VF
    Eur J Med Chem; 2006 Jan; 41(1):80-7. PubMed ID: 16300859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Four substituted pyrazolines.
    Chopra D; Mohan TP; Vishalakshi B; Row TN
    Acta Crystallogr C; 2007 Dec; 63(Pt 12):o746-50. PubMed ID: 18057630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Critical studies on the modern method for determination of resistance to sulfonamides].
    WILDE J
    Z Gesamte Inn Med; 1957 Feb; 12(3):100-8. PubMed ID: 13434229
    [No Abstract]   [Full Text] [Related]  

  • 31. Amide derivatives of sulfonamides and isoniazid: synthesis and biological evaluation.
    Husain A
    Acta Pol Pharm; 2009; 66(5):513-21. PubMed ID: 19894647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pyrazolic sulfanilamides. 8. Chloro-derivatives of 1-phenyl-4-sulfanilamidopyrazole].
    Alberti C; Tironi C
    Farmaco Sci; 1966 Dec; 21(2):883-91. PubMed ID: 5983416
    [No Abstract]   [Full Text] [Related]  

  • 33. 5-Heteroatom substituted pyrazoles as canine COX-2 inhibitors. Part III: molecular modeling studies on binding contribution of 1-(5-methylsulfonyl)pyrid-2-yl and 4-nitrile.
    Sakya SM; Hou X; Minich ML; Rast B; Shavnya A; DeMello KM; Cheng H; Li J; Jaynes BH; Mann DW; Petras CF; Seibel SB; Haven ML
    Bioorg Med Chem Lett; 2007 Feb; 17(4):1067-72. PubMed ID: 17126015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and pharmacological evaluation of N-phenyl-acetamide sulfonamides designed as novel non-hepatotoxic analgesic candidates.
    Barbosa ML; Melo GM; da Silva YK; Lopes Rde O; de Souza ET; de Queiroz AC; Smaniotto S; Alexandre-Moreira MS; Barreiro EJ; Lima LM
    Eur J Med Chem; 2009 Sep; 44(9):3612-20. PubMed ID: 19327871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pyrazolo[3,4-d]pyrimidine derivatives as COX-2 selective inhibitors: synthesis and molecular modelling studies.
    Raffa D; Maggio B; Plescia F; Cascioferro S; Raimondi MV; Plescia S; Cusimano MG
    Arch Pharm (Weinheim); 2009 Jun; 342(6):321-6. PubMed ID: 19479756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experimental & clinical research on 3-(p-aminobenzene-sulfonamido)-2-phenyl-pyrazole.
    TADDEI C; RINETTI M; BOSELLI G; LIMONGELLI F
    Minerva Med; 1958 Dec; 49(100):4752-7. PubMed ID: 13622391
    [No Abstract]   [Full Text] [Related]  

  • 37. Synthesis and antimicrobial activity of some novel derivatives of benzofuran: part 1. Synthesis and antimicrobial activity of (benzofuran-2-yl)(3-phenyl-3-methylcyclobutyl) ketoxime derivatives.
    Koca M; Servi S; Kirilmis C; Ahmedzade M; Kazaz C; Ozbek B; Otük G
    Eur J Med Chem; 2005 Dec; 40(12):1351-8. PubMed ID: 16129517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective extraction, separation and speciation of iron in different samples using 4-acetyl-5-methyl-1-phenyl-1H-pyrazole-3-carboxylic acid.
    Saçmaci S; Kartal S
    Anal Chim Acta; 2008 Aug; 623(1):46-52. PubMed ID: 18611456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Trial with a prolonged-action sulfamide: 3-(p-amino benzenesulfonamido)-2-phenyl-pyrazole in the treatment of urological diseases].
    Hospital (Rio J); 1959 May; 55(5):671-6. PubMed ID: 13664222
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hypoglycemic sulfonamides and bacterial flora].
    ZAGURY D; DESPLACES A; SACQUET E; GHATA J
    Presse Med (1893); 1962 Apr; 70():929-30. PubMed ID: 14009582
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.